Quick Answer
ACADIA PHARMACEUTICALS INC reported Research And Development Expense of $328.80 million for the year ending 2025.
- ACADIA PHARMACEUTICALS INC showed an increase of +8.4% in Research And Development Expense from 2024 to 2025.
- This data is from ACADIA PHARMACEUTICALS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), ACADIA PHARMACEUTICALS INC's Research And Development Expense has grown by 690.7%.
- Historical annual values: Fiscal year 2025: $328.80 million | Fiscal year 2024: $303.25 million | Fiscal year 2023: $351.62 million | Fiscal year 2022: $361.58 million | Fiscal year 2021: $239.42 million | Fiscal year 2020: $319.13 million | Fiscal year 2019: $240.39 million | Fiscal year 2018: $187.16 million | Fiscal year 2017: $149.19 million | Fiscal year 2016: $99.28 million | Fiscal year 2015: $73.87 million | Fiscal year 2014: $60.60 million | Fiscal year 2013: $26.72 million | Fiscal year 2012: $18.79 million | Fiscal year 2011: $17.31 million | Fiscal year 2010: $20.58 million | Fiscal year 2009: $41.59 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: